Chinese expert consensus on the management of hypertension in adults with type 2 diabetes

被引：1

作者：

Pan, Xiaohui ^{[1
]}

He, Hongbo ^{[2
,3
]}

Bao, Yuqian ^{[4
]}

Bi, Yan ^{[5
]}

Chen, Luyuan ^{[6
,7
]}

Chen, Xiaoping ^{[8
]}

Fang, Hui ^{[9
]}

Feng, Wenhuan ^{[5
]}

Gao, Ling ^{[10
]}

Guo, Lixin ^{[11
,12
,13
]}

Guo, Yifang ^{[14
]}

Han, Yaling ^{[15
,16
]}

Hua, Qi ^{[17
]}

Li, Nanfang ^{[18
]}

Li, Quanmin ^{[19
]}

Li, Yan ^{[20
,21
]}

Li, Yong ^{[22
]}

Li, Xialian ^{[23
]}

Liu, Jing ^{[24
]}

Ma, Huijuan ^{[25
]}

Mu, Jianjun ^{[26
]}

Nong, Kailei ^{[1
]}

Shang, Huiqian ^{[27
]}

Shen, Yunfeng ^{[28
]}

Shi, Zhongwei ^{[29
]}

Sun, Fang ^{[30
]}

Sun, Ningling ^{[24
]}

Tao, Jun ^{[31
]}

Wang, Jiguang ^{[21
,32
]}

Wang, Xinling ^{[33
]}

Wu, Jing ^{[34
]}

Xiao, Xinhua ^{[35
]}

Xie, Liangdi ^{[36
]}

Xu, Jing ^{[37
,38
]}

Ye, Hongying ^{[39
]}

Yu, Dongni ^{[11
]}

Yuan, Hong ^{[40
]}

Zhang, Huijie ^{[41
]}

Zhang, Jian ^{[42
]}

Zhang, Lili ^{[43
]}

Zhang, Yuqing ^{[44
]}

Zhou, Jiaqiang ^{[45
]}

Zhou, Xinli ^{[46
]}

Zhu, Dalong ^{[5
]}

Zhu, Tiehong ^{[46
]}

Li, Sheyu ^{[1
]}

Zhu, Zhiming ^{[2
,3
]}

机构：

[1] Sichuan Univ, West China Hosp, Dept Endocrinol & Metab, Chengdu, Peoples R China

[2] Army Med Univ, Chongqing Inst Hypertens, Chongqing, Peoples R China

[3] Chongqing Inst Hypertens, Chongqing, Peoples R China

[4] Shanghai Jiao Tong Univ, Dept Otorhinolaryngol, Peoples Hosp 6, Sch Med, Shanghai, Peoples R China

[5] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Endocrinol, Nanjing, Peoples R China

[6] Peoples Hosp Guangdong Prov, Dept Cardiol, Guangzhou, Peoples R China

[7] Guangzhou Inst Cardiovasc Dis, Guangzhou, Peoples R China

[8] Sichuan Univ, West China Hosp, Dept Cardiol, Chengdu, Peoples R China

[9] Hebei Med Univ, Tangshan City Workers Hosp, Dept Endocrinol, Tangshan 063000, Hebei, Peoples R China

[10] Wuhan Univ, Dept Endocrinol, Renmin Hosp, Wuhan, Peoples R China

[11] Beijing Hosp, Minist Hlth, Dept Endocrinol, Beijing, Peoples R China

[12] China Natl Ctr Bioinformat, Beijing, Peoples R China

[13] Chinese Acad Med Sci, Inst Geriatr, Beijing, Peoples R China

[14] Hebei Gen Hosp, Dept Geriatr Cardiovasc Med, Shijiazhuang, Peoples R China

[15] Gen Hosp Northern Theater Command, Dept Cardiol, Shenyang, Peoples R China

[16] Shenyang Mil Command, Shenyang, Peoples R China

[17] Capital Med Univ, Xuanwu Hosp, Dept Cardiol, Beijing, Peoples R China

[18] Peoples Hosp Xinjiang Uygur Autonomous Reg, Ctr Hypertens, Urumqi, Peoples R China

[19] PLA Rocket Force Characterist Med Ctr, Dept Endocrinol, Beijing, Peoples R China

[20] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Cardiol, Shanghai, Peoples R China

[21] Shanghai Res Inst Hypertens, Shanghai, Peoples R China

[22] Fudan Univ, Huashan Hosp, Dept Cardiol, Shanghai, Peoples R China

[23] Zhengzhou Univ, Affiliated Hosp 1, Dept Endocrinol, Zhengzhou, Peoples R China

[24] Peking Univ Peoples Hosp, Cardiovasc Med Dept, Beijing, Peoples R China

[25] Hebei Med Univ, Affiliated Hosp 1, Dept Endocrinol, Shijiazhuang, Hebei, Peoples R China

[26] Xi An Jiao Tong Univ, Dept Reprod Med, Affiliated Hosp 1, Xian, Peoples R China

[27] Zunyi Med Univ, Dept Cardiovasc Med, Affiliated Hosp, Zunyi, Peoples R China

[28] Sun Yat Sen Univ, Affiliated Hosp 8, Dept Endocrinol & Metab, Shenzhen, Peoples R China

[29] Army Med Univ, Daping Hosp, Army Special Med Ctr, Dept Hypertens & Endocrinol, Chongqing, Peoples R China

[30] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou, Peoples R China

[31] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Hypertens, Shanghai, Peoples R China

[32] Peoples Hosp Xinjiang Uygur Autonomous Reg, Dept Endocrinol, Urumqi, Peoples R China

[33] Cent South Univ, Dept Endocrinol, Xiangya Hosp, Changsha, Peoples R China

[34] Univ South China, Affiliated Hosp 1, Dept Endocrinol & Metab, Changsha, Peoples R China

[35] Fujian Med Univ, Affiliated Hosp 1, Fuzhou, Peoples R China

[36] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Endocrinol, Xian, Peoples R China

[37] Army Med Univ, Xinqiao Hosp, Dept Endocrinol, Chongqing, Peoples R China

[38] Fudan Univ, Huashan Hosp, Dept Endocrinol, Shanghai, Peoples R China

[39] Cent South Univ, Dept Gynecol, Xiangya Hosp 3, Changsha, Peoples R China

[40] Southern Med Univ, Nanfang Hosp, Dept Endocrinol, Guangzhou, Peoples R China

[41] Hubei Prov Hosp TCM, Dept Encephalopathy, Wuhan, Peoples R China

[42] Chongqing Med Univ, Dept Cardiol, Affiliated Hosp 2, Chongqing, Peoples R China

[43] Chinese Acad Med Sci, Dept Cardiovasc Surg, Fuwai Hosp, Beijing, Peoples R China

[44] Zhejiang Univ, Sir Run Shaw Hosp, Sch Med, Dept Endocrinol & Metab, Hangzhou, Peoples R China

[45] Shandong First Med Univ, Dept Endocrinol & Metab, Shandong Prov Hosp, Jinan, Peoples R China

[46] Tianjin Med Univ, Dept Endocrinol & Metab, Gen Hosp, Tianjin, Peoples R China

来源：

JOURNAL OF EVIDENCE BASED MEDICINE | 2024年 / 17卷 / 04期

基金：

中国国家自然科学基金;

关键词：

anti-hypertensive treatment; blood pressure monitor; hypertension; screening for hypertension; type; 2; diabetes; ALL-CAUSE MORTALITY; BLOOD-PRESSURE; CARDIOVASCULAR EVENTS; DISEASE; EFFICACY; SODIUM; HOME; MELLITUS; DYSFUNCTION; INHIBITORS;

D O I：

10.1111/jebm.12655

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Both hypertension and type 2 diabetes are attributable to premature death, cardiovascular and kidney diseases with largely overlapping population. Followed the GRADE approach, this expert consensus aimed to reduce the cardiovascular and kidney death and disability due to hypertension and minimize the treatment burden in adults with type 2 diabetes. Through online survey and discussion, a multidisciplinary team comprehensively prioritized seven key guideline questions. Informed by the evidence synthesis and online discussion, the team developed 12 recommendations under the GRADE Evidence-to-decision (EtD) framework. The recommendations covered the screening of hypertension in adults diagnosed with type 2 diabetes but not hypertension and the monitoring, lifestyle interventions, and medications in those diagnosed with type 2 diabetes and hypertension.

引用

页码：851 / 864

页数：14

共 50 条

[31] Association between surrogate indicators of insulin resistance and risk of type 2 diabetes combined with hypertension among Chinese adults: two independent cohort studies
Dong, Jing
Liu, Yu-Hong
Lu, Ya-Ke
Hu, Li-Kun
Chen, Ning
Ma, Lin-Lin
Chu, Xi
Yan, Yu-Xiang
NUTRITION & METABOLISM, 2022, 19 (01)
[32] Hypertension and Hypercholesterolemia are Associated with Cataract Development in Patients with Type 2 Diabetes
Tomic, Martina
Vrabec, Romano
Rastegorac, Petar
Ljubic, Spomenka
Bulum, Tomislav
Rahelic, Dario
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 2021, 28 (05) : 475 - 481
[33] Effectiveness of mHealth management with an implantable glucose sensor and a mobile application among Chinese adults with type 2 diabetes
Guo, Mengna
Meng, Fanli
Guo, Qing
Bai, Tiantian
Hong, Yanyan
Song, Fengbin
Ma, Yan
JOURNAL OF TELEMEDICINE AND TELECARE, 2023, 29 (08) : 632 - 640
[34] Antihypertensive and metabolic effects of high-dose olmesartan and telmisartan in type 2 diabetes patients with hypertension
Arao, Tadashi
Okada, Yosuke
Mori, Hiroko
Nishida, Keiko
Tanaka, Yoshiya
ENDOCRINE JOURNAL, 2013, 60 (05) : 563 - 570
[35] 2020 Consensus of Taiwan Society of Cardiology on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases
Chiang, Chern-En
Ueng, Kwo-Chang
Chao, Ting-Hsing
Lin, Tsung-Hsien
Wu, Yih-Jer
Wang, Kang-Ling
Sung, Shih-Hsien
Yeh, Hung-, I
Li, Yi-Heng
Liu, Ping-Yen
Chang, Kuan-Cheng
Shyu, Kou-Gi
Huang, Jin-Long
Tsai, Cheng-Dao
Hung, Huei-Fong
Liu, Ming-En
Chao, Tze-Fan
Cheng, Shu-Meng
Cheng, Hao-Min
Chu, Pao-Hsien
Yin, Wei-Hsian
Wu, Yen-Wen
Chen, Wen-Jone
Lai, Wen-Ter
Lin, Shing-Jong
Yeh, San-Jou
Hwang, Juey-Jen
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2020, 83 (07) : 587 - 621
[36] Exploring Effects of Type 2 Diabetes on Cognitive Functioning in Older Adults
Yeung, Sophie E.
Fischer, Ashley L.
Dixon, Roger A.
NEUROPSYCHOLOGY, 2009, 23 (01) : 1 - 9
[37] Resistant Hypertension in Adults With Type 1 or 2 Diabetes: A Structured Diagnostic Approach
McFarlane, Philip A.
CANADIAN JOURNAL OF DIABETES, 2018, 42 (02) : 173 - 178
[38] INTERNATIONAL CONSENSUS GUIDELINES: REASONABLE ADJUSTMENTS IN THE MANAGEMENT OF TYPE 2 DIABETES IN ADULTS WITH INTELLECTUAL AND DEVELOPMENTAL DISABILITIES
Truesdale, M.
Taggart, L.
Trip, H.
Conder, J.
Whitehead, L.
Scott, J.
Rouse, L.
Lunsky, Y.
Redquest, B.
JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2019, 63 (07) : 813 - 813
[39] High Sodium Intake Is Associated With Masked Hypertension in Japanese Patients With Type 2 Diabetes and Treated Hypertension
Uzu, Takashi
Nakao, Keiko
Kume, Shinji
Araki, Hisazumi
Isshiki, Keiji
Araki, Shin-Ichi
Kawai, Hiromichi
Ugi, Satoshi
Kashiwagi, Atsunori
Maegawa, Hiroshi
AMERICAN JOURNAL OF HYPERTENSION, 2012, 25 (11) : 1170 - 1174
[40] Seasonal variations on endothelium-dependent flow-mediated vasodilation in adults with type 2 diabetes and nondiabetic adults with hypertension and/or dyslipidaemia who perform regular exercise
Honda, Hiroto
Igaki, Makoto
Komatsu, Motoaki
Tanaka, Shin-ichiro
ENDOCRINOLOGY DIABETES & METABOLISM, 2021, 4 (01)

← 1 2 3 4 5 →